Tomás José González‐López

Statistics

Publications

Citations

610

H-Index

Active since

2013

Affiliations

Hospital Universitario de Burgos(Current)

Hospital El Bierzo

Instituto de Investigación Biomédica de Salamanca

Hospital Universitario Río Hortega

Hospital General Universitario Gregorio Marañón

Tomás José González‐López is an author at Hospital Universitario de Burgos specializing in medicine, immunopharmacology, and immune-mediated thrombocytopenia.

ORCID

Publications per year

2013–2024

Publications

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia

Cristina Jiménez, Elena Sebastián, Carmen Chillón et al. · Leukemia · 2013 · 267 citations · Full text

Life Sciences, Genetics, Molecular Genetics +4

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

Tomás José González‐López, Cristina Pascual, María Román et al. · American Journal of Hematology · 2014 · 149 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

José Ramón González‐Porras, María Eva Mingot‐Castellano, Marcio Andrade et al. · British Journal of Haematology · 2014 · 78 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

Tomás José González‐López, María Román, Cristina Pascual et al. · European Journal Of Haematology · 2015 · 49 citations · Full text

Medicine, Hematology, Pharmacotherapy +10

Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice

Tomás José González‐López, Nuria Bermejo, Rocio Cardesa‐Cabrera et al. · Blood · 2024 · 29 citations

Medicine, Hematology, Pharmacology +7

1–5 of 8